Back to results
US 11,692,029 B2Granted
Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors
AssigneeThe Schepens Eye Research Institute, Inc.
InventorsJi Min, Kin-Sang Cho, Dong Feng Chen
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for treating optic neuropathic disorders.
Claims20
A method for treating glaucoma in a subject comprising intravitreally administering to the eye an antagonistic CSF1 receptor antibody.
A method of preventing or treating glaucoma in a subject comprising intravitreally administering to the eye, a pharmaceutical composition comprising a therapeutically effective amount of an antagonistic colony stimulating factor-1 (CSF1) receptor antibody, thereby preventing or treating the glaucoma.
Dependencies are inferred from the claim text.